Atopic dermatitis in adolescents: assessment of quality of life, anxiety, and depression levels
Allergologia et Immunopathologia, cilt.54, sa.2, ss.85-92, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 54 Sayı: 2
- Basım Tarihi: 2026
- Doi Numarası: 10.15586/aei.v54i2.1561
- Dergi Adı: Allergologia et Immunopathologia
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, DIALNET, Health Research Premium Collection (ProQuest)
- Sayfa Sayıları: ss.85-92
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
The current study evaluated the quality of life, anxiety, and depression in adolescents diagnosed with atopic dermatitis. Adolescents diagnosed with atopic dermatitis (AD) (n = 25) who were not receiving regular treatment were compared with 41 healthy adolescents. Disease severity in adolescents with AD was evaluated using the Scoring Atopic Dermatitis (SCORAD) index and the Children’s Dermatology Life Quality Index (CDLQI). In both groups, depression and anxiety were assessed using the Beck Depression and Anxiety Scales. Results indicated that quality of life was severely affected (Median = 16.0, AD group). The mean anxiety and depression scores were 34.0 and 16.0, respectively, in the AD group, and 35.0 and 11.0, respectively, in the control group. Pruritus severity was significantly correlated with both anxiety (r = 0.524, p = 0.01) and depression (r = 0.472, p = 0.02). Quality of life decreased in adolescents with AD, while signs and symptoms of anxiety and depression were more prevalent. The results also revealed a significant relationship between pruritus severity and psychological burden. These findings suggest that it is important to evaluate patients with AD using a holistic approach, not solely based on dermatological assessment but in concert with psychosocial needs.